
Immune checkpoint inhibitors are transformative new immunotherapeutics that can unleash the body’s immune system to attack and destroy cancer cells.

Research-driven advances in identifying genetic mutations that fuel tumor growth have set the stage for a new era of precision medicine.
Learn More
Early detection of cancer using artificial intelligence-powered devices and software is a rapidly evolving research area with exciting new developments.
Learn More
In the United States, 40 percent of all cancers are associated with modifiable risk factors.
Learn More